help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutanen, E. M.
Right arrow Articles by Makinen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutanen, E. M.
Right arrow Articles by Makinen, T.

Journal of Clinical Endocrinology & Metabolism, Vol 66, 173-180, Copyright © 1988 by Endocrine Society


ARTICLES

Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action

EM Rutanen, F Pekonen and T Makinen
Minerva Institute for Medical Research, Helsinki, Finland.

The human secretory phase endometrium synthesizes and secrets a 34K insulin-like growth factor (IGF)-binding protein designated placental protein 12. We now report that membrane preparations of human endometrium possess IGF receptors that complete with the soluble binding protein for binding to IGF-I. Multiplication-stimulating activity and insulin were 1% and 0.1% as potent as recombinant (Thr59)IGF-I in inhibiting the binding of [125I](Thr59)IGF-I to endometrial membranes. Scatchard plots for the IGF-I binding data were curvilinear, and the apparent affinities [Ka = 1.4 +/- 0.2 ( +/- SEM) X 10(9) M-1] for (Thr59)IGF-I (high affinity site) did not change during the menstrual cycle. Affinity cross-linking of [125I](Thr59)IGF-I to endometrial membranes revealed two major bands with mol wt of 130K and 260K on sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. The 130K band is consistent with the alpha-subunit of the type I IGF receptor. The 260K band is either the type II IGF receptor or represents cross-linking (dimer) of two alpha-subunits of the type I receptor. A less intense band at about 40K was also seen in all membrane preparations. It comigrated with the cross-linked purified 34K binding protein. The band was more intensely labeled when the tracer was cross-linked to proteins in the cytosol fractions of late secretory phase endometria. By specific RIA, the 34K binding protein was detected in the cytosol of late secretory phase endometria only. Newly synthesized binding protein, which contaminated membrane preparations, caused an apparent increase in the binding of (Thr59)IGF- I to the membranes prepared from late secretory phase endometria when studied by competitive binding assay. In contrast, purified binding protein prevented the binding of [125I](Thr59)IGF-I to membrane receptors, as confirmed by affinity cross-linking. These results suggest that the 34K IGF-binding protein, secreted by the human endometrium in a cyclic fashion, has a significant role in inhibiting the receptor binding and, thus, the possible biological action of IGF-I in the endometrium in an autocrine/paracrine manner.


This article has been cited by other articles:


Home page
IOVSHome page
B. J. Fan, D. Y. Wang, C. C. Y. Tham, D. S. C. Lam, and C. P. Pang
Gene Expression Profiles of Human Trabecular Meshwork Cells Induced by Triamcinolone and Dexamethasone
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1886 - 1897.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Ihnatovych, W. Hu, J. L. Martin, A. T. Fazleabas, P. de Lanerolle, and Z. Strakova
Increased Phosphorylation of Myosin Light Chain Prevents in Vitro Decidualization
Endocrinology, July 1, 2007; 148(7): 3176 - 3184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. G. Slomiany and S. A. Rosenzweig
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C746 - C753.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. G. Slomiany and S. A. Rosenzweig
IGF-1-Induced VEGF and IGFBP-3 Secretion Correlates with Increased HIF-1{alpha} Expression and Activity in Retinal Pigment Epithelial Cell Line D407
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2838 - 2847.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Strakova, M. Szmidt, S. Srisuparp, and A. T. Fazleabas
Inhibition of Matrix Metalloproteinases Prevents the Synthesis of Insulin-Like Growth Factor Binding Protein-1 during Decidualization in the Baboon
Endocrinology, December 1, 2003; 144(12): 5339 - 5346.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Ishibashi, Y. Takagi, K. Mori, S. Naruse, H. Nishino, B. Y. J. T. Yue, and S. Kinoshita
cDNA Microarray Analysis of Gene Expression Changes Induced by Dexamethasone in Cultured Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3691 - 3697.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Maures and C. Duan
Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1
Endocrinology, July 1, 2002; 143(7): 2722 - 2731.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Kajantie, L. Dunkel, E.-M. Rutanen, M. Seppala, R. Koistinen, A. Sarnesto, and S. Andersson
IGF-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1, and Postnatal Growth in Very Low Birth Weight Infants
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2171 - 2179.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Strakova, S. Srisuparp, and A. T. Fazleabas
Interleukin-1{beta} Induces the Expression of Insulin-Like Growth Factor Binding Protein-1 during Decidualization in the Primate
Endocrinology, December 1, 2000; 141(12): 4664 - 4670.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T Hytinantti, E-M Rutanen, M Turpeinen, R Sorva, and S Andersson
Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 17F - 20.
[Abstract] [Full Text]


Home page
Reproductive SciencesHome page
J. Gogusev, J. B. de Joliniere, L. Telvi, M. Doussau, A. Stojkoski, and M. Levradon
Cellular and Genetic Constitution of Human Endometriosis Tissues
Reproductive Sciences, March 1, 2000; 7(2): 79 - 87.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. O. Nygren, A. Thorell, M. Soop, S. Efendic, K. Brismar, F. Karpe, K. S. Nair, and O. Ljungqvist
Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery
Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E140 - E148.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. Martina, E. Kim, U. Chitkara, N. C. Wathen, T. Chard, and L. C. Giudice
Gestational Age-Dependent Expression of Insulin-Like Growth Factor-Binding Protein-1 (IGFBP-1) Phosphoisoforms in Human Extraembryonic Cavities, Maternal Serum, and Decidua Suggests Decidua as the Primary Source of IGFBP-1 in these Fluids during Early Pregnancy
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1894 - 1898.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society